Compare Amphastar Pharmaceuticals Inc (AMPH) vs Eaton Corporation plc (ETN) Price & Performance

AMPH trades at $20.78, up 4.9% today, with a bullish technical signal supported by moving averages. The stock shows mixed earnings performance with Q2 2026 beating estimates but Q1 and Q4 2025 missing. Fundamentals remain solid with a 10.76% net margin and reasonable valuation at 12.02 P/E. Recent news highlights Q2 2026 results and strategic shift toward proprietary drugs.

Outlook is cautiously optimistic with growth supported by new product launches, though regulatory risks and earnings volatility pose challenges. Analyst sentiment is mixed with 25% buy ratings but majority hold recommendations. The stock offers value but requires monitoring of FDA developments and earnings consistency.

Eaton (ETN) trades at $448.68, up 0.11% on the day and near its 52-week high, supported by a bullish technical trend and strong fundamental performance. The company reported three consecutive quarterly earnings beats, with Q2 2026 EPS of $3.15 exceeding the $3.07 estimate, and raised its full-year outlook. Revenue growth is robust, driven by surging demand in electrical and aerospace segments, particularly from data center expansion.

The outlook remains positive given raised guidance and analyst consensus, but the stock's premium valuation (P/E of 45.31) poses a risk if growth moderates. Key opportunities include exposure to AI-driven power infrastructure spending, while risks involve execution challenges and macroeconomic sensitivity. The consensus price target of $496.50 implies ~11% upside from current levels.